Key result
Enoximone significantly improved cardiac output (1684 vs 1471 ml/min, p<0.05) compared to control, whereas isoproterenol did not reverse protamine-induced deterioration of cardiac function.
Why the study?
Does enoximone or isoproterenol improve hemodynamic activity in a canine model of protamine cardiotoxicity?
Does enoximone or isoproterenol improve hemodynamic activity in a canine model of protamine cardiotoxicity?
Absolute Event Rate: 1684% vs 1471%
p-value: p=<0.05
Enoximone, a phosphodiesterase inhibitor, effectively reverses the deterioration of cardiac function following protamine administration in a canine model, whereas the beta-agonist isoproterenol does not.
Enoximone merits further study for protamine cardiotoxicity; leaves open translation to humans and should not change practice.
In this study we investigated the effects of isoproterenol and enoximone on protamine cardiotoxicity because administration of protamine for heparin reversal during open heart surgery depresses left ventricular function. Eighteen mongrel dogs were entered into this study. After induction of general anesthesia and a stabilization period, a thermodilution catheter was inserted via the jugular vein. Another 2 catheters were inserted into the left ventricle and femoral artery. Heparin and protamine were used in all animals. Heparin dosage was 300 U/kg, and protamine dosage was 4.5 mg/kg. The animals were divided into 3 groups. Six animals received enoximone (5 micrograms/kg per min), 6 animals received isoproterenol (0.05 microgram/kg per min), and 6 animals received no inotropic agent. Measurements were performed before treatment, 5 min after protamine administration, and at 15-min intervals for 1 h. Cardiac output (CO), mean arterial pressure, pulmonary capillary wedge pressure, first derivative of left ventricular pressure (1 +/-) left ventricular systolic pressure, and heart rate were measured. CO was 1582 +/- 34 ml/min in the isoproterenol group (I + P), 1684 +/- 61 ml/min in the enoximone group (E + P), and 1471 +/- 37 ml/min in the protamine group (P) (p < 0.05 E + P vs I + P and P) 60 min after protamine administration. The first derivative of left ventricular pressure (dP/dt) was 1995 +/- 61 mmHg/sec in the I + P group, 2320 +/- 85 mmHg/sec in the E + P group, and 1816 +/- 48 mmHg/sec in the P group (p < 0.05 E + P vs I + P and P). In our experimental study, the isoproterenol and protamine combination did not increase hemodynamic activity. However, isoproterenol alone significantly increased hemodynamic activity as determined by dP/dt values. Protamine administration impairs the effects of beta agonists on the myocardium. In the protamine group, CO and pressure-dependent values were significantly reduced. Isoproterenol administration did not reverse this deterioration because of the loss of the beta-receptor activity. Inotropic agents acting through the beta-adrenergic system have partial effects on myocardium. Enoximone, a phosphodiesterase inhibitor, reverses deterioration of cardiac function after protamine administration because it increases myocardial function via the phosphodiesterase system.
No takes yet. Share an insight, caveat, or question.
Katırcıoğlu et al. (1998) studied Protamine cardiotoxicity (n=18). Enoximone and Isoproterenol vs. No inotropic agent was evaluated on Cardiac output (CO) at 60 min after protamine administration (p=<0.05). Enoximone significantly improved cardiac output (1684 vs 1471 ml/min, p<0.05) compared to control, whereas isoproterenol did not reverse protamine-induced deterioration of cardiac function.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: